FABRAZYME 5 MG

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
AGALSIDASE BETA 5 MG/ML
Available from:
SANOFI - AVENTIS ISRAEL LTD
ATC code:
A16AB04
Pharmaceutical form:
POWDER FOR CONCENTRATE FOR INFUSION
Administration route:
I.V
Manufactured by:
GENZYME CORPORATION, USA
Therapeutic group:
AGALSIDASE BETA
Therapeutic indications:
Long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease.
Authorization number:
131993107900
Authorization date:
2012-06-01

Similar products

Search alerts related to this product

View documents history

Share this information